Home | Archive of Evens | The Lancet Asia Medical Forum 2007

The Lancet Asia Medical Forum 2007

The Lancet Asia Medical Forum 2007

Asia & Cancer Management in the 21st Century

City: Singapore

Country: SINGAPORE

Date : 21 April 2007 - 22 April 2007

http://www.asiamedicalforum.com/





The Lancet Asia Medical Forum 2007 will offer a unique opportunity for leading regional and international experts to come together with a unified goal of addressing the specific issues surrounding the provision, and future needs, of effective cancer care in Asia. The Forum will focus on the ten most prevalent cancers in Asia-Pacific and will examine aspects of prevention, diagnosis, treatment, and palliation. In addition, world opinion-leaders will discuss cancer aetiology, health-care systems, and the challenges of providing effective disease management with limited resources, along with views on state-of-the-art techniques in the areas of diagnostics, medical oncology, radiation therapy, and surgical oncology. Finally, the Forum will also host a didactic workshop on how to run a clinical trial, presented by world-renowned specialists, to help foster new clinical research.

Forum Programme


SATURDAY, 21 APRIL 2007


INTRODUCTION

8:50 a.m.

Dr Richard Horton
Editor-in-Chief and Publisher, The Lancet, UK
Mr Khaw Boon Wan Minister for Health, Singapore

OPENING SESSION

Moderator
Dr Richard Horton Editor-in-Chief and Publisher, The Lancet, UK

9:10 a.m. Keynote Lecture 1
Cancer incidence: an Asian perspective

Dr D Max Parkin Clinical Trials Service Unit & Epidemiological Studies Unit, University of Oxford, Oxford, UK

9:40 a.m. Asian cancer aetiology and prevention
Prof Kazuo Tajima Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

10:00 a.m. Clinical research in Asia: the importance of collaboration and the role of IARC and the WHO
Dr Peter Boyle
International Agency for Research on Cancer, Lyon, France

10:20 a.m.

World Cancer Declaration and compliance in Asia: role of the UICC
Dr Franco Cavalli
International Union Against Cancer, Geneva, Switzerland

10:40 a.m. Role of multidisciplinary care and regional centres of excellence
Prof Soo Khee Chee National Cancer Centre of Singapore, Singapore

11:00 a.m. Delivery of quality cancer care in countries with limited infrastructure
Prof Ketayun Dinshaw
Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, India

11:20 a.m. TEA BREAK
PREVENTION AND DIAGNOSIS I

Moderator
Prof Jatin P Shah
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

11:50 a.m.

H pylori, COX-2 inhibitors, and prevention of gastric cancer
Prof Joseph J Sung
Institute of Digestive Diseases, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

12:10 p.m.

Prevention and surveillance of hepatitis-B-related hepatocellular carcinoma
Prof Yun-Fan Liaw
Liver Research Unit, Chang Gung University, Taipei, Taiwan

12:30 p.m. 15 years of follow-up: what have we learned from the oesophageal Nutrition Intervention Trials in Linxian, China?
Prof You-Lin Qiao
Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences, Beijing, China

12:50 p.m. Oral cancers – Asian Perspective
Prof Anil D’Cruz
Head and Neck Services, Tata Memorial Hospital, Mumbai, India

1:10 p.m. Current developments in prevention strategies and diagnostics in colorectal cancer
Prof Toshiaki Watanabe
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
1:35 p.m. LUNCH AND POSTER SESSION I
DISEASE MANAGEMENT I

Moderator

Prof Joseph J Sung
Institute of Digestive Diseases, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

2:35 p.m.

Management of stomach cancer
Prof Chew-Wun Wu
Department of Surgery, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan

2:55 p.m.
Current management strategies for liver cancer
Prof Morito Monden Department of Surgery, Osaka University, Osaka, Japan

3:15 p.m. Oesophageal cancer, East and West: same name, different disease
Prof John Wong
Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Hong Kong

3:35 p.m. State-of-the-art management of oral cancer and future challenges
Prof Jatin P Shah
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

3:55 p.m. Recent advances in colorectal cancer: where to from here?
Prof John Zalcberg Department of Medical Oncology, Division of Haematology & Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
4:20 p.m. TEA BREAK
CLINICAL TRIALS IN ASIA

Moderator

Prof Steven Piantadosi
Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA

4:50 p.m. Keynote Lecture 2:
Opportunities for research in breast cancer in the developing world
Prof Indraneel Mittra
Bhopal Memorial Hospital and Research Centre, Bhopal, India

5:20 p.m. Workshop:
Running a randomised clinical trial


Chair Person: Prof Steven Piantadosi Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA

Speakers include:

Trial design, optimisation and data management
Prof Steven Piantadosi
Oncology Biostatistics, Johns Hopkins School of Medicine, Baltimore, MD, USA

Improving recruitment to randomised clinical trials in cancer
Prof Lesley Fallowfield
Psychosocial Oncology Group, University of Sussex, Brighton, UK

Trial infrastructure; Collaboration; Funding
Prof Fred Hirsch
University of Colorado Cancer Center, CO, USA

Running an ethical trial
Prof Maurie Markman
The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Analysis; Data interpretation; Reporting
Prof Masakazu Toi
Department of Surgery [Breast Surgery], Graduate School of Medicine, Kyoto University, Kyoto, Japan

6:50 p.m. END OF DAY 1


SUNDAY, 22 APRIL 2007

OPENING SESSION

Moderator
Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway

9:00 a.m. Keynote Lecture 3:
Cancer management and traditional medicine
Prof Tony Mok Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

PREVENTION AND DIAGNOSIS II

Moderator
Prof Sophie Fossa Norwegian Radium Hospital, Oslo, Norway

9:30 a.m.

Chemoprevention for lung cancer
Prof Fred Hirsch University of Colorado Cancer Center, CO, USA

9:50 a.m. Diagnosis and prevention of breast cancer by nipple aspiration fluid
Prof Masakazu Toi
Department of Surgery (Breast Surgery), Graduate School of Medicine, Kyoto University, Kyoto, Japan

10:10 a.m. Strategies for cervical cancer prevention: the right one for the right community
A/Prof Eng-Hseon Tay Department of Gynaecological Subspecialties and Gynaecological Oncology Unit, KK Women’s & Children’s Hospital, Singapore

10:30 a.m. Strategies for the prevention of ovarian cancer
Prof Maurie Markman The University of Texas MD Anderson Cancer Center, Houston, TX, USA

10:50 a.m. Early diagnosis of prostate cancer without unnecessary treatment in those who will not benefit
Prof James Denham
University of Newcastle, Newcastle, Australia
11:15 a.m. TEA BREAK
DISEASE MANAGEMENT II

Moderator
Prof Fred Hirsch
University of Colorado Cancer Center, CO, USA

11:45 a.m. Treatment of advanced non-small-cell lung cancer with chemotherapy: An Asian experience
Prof Sumitra Thongprasert
Department of Medicine, Chiang Mai University, Chiang Mai, Thailand

12:05 p.m.
The Breast Health Global Initiatives Foundation: clinical practice guidelines for the management of breast cancer in developing countries
Prof Cheng-Har Yip Department of Surgery, University of Malaya Medical Centre, Kuala Lumpur, Malaysia

12:25 p.m . Management of cancer in uterine cervix
Prof Chyong-Huey Lai
Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan

12.45 p.m Salvage therapy of epithelial ovarian cancer: what is the appropriate setting for the Asian situation?
Dr Sarikapan Wilailak
Department of Obstetrics and Gynaecology, Ramathibodi Hospital, Bangkok, Thailand

1:05 p.m. Management of prostate cancer
Prof Malcolm Mason Department of Oncology and Palliative Medicine, Wales College of Medicine, Cardiff University, Cardiff, UK

1:30 p.m. LUNCH AND POSTER SESSION II
PALLIATIVE CARE AND QUALITY OF LIFE

Moderator

Prof Tony Mok
Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

2:30 p.m. The need for oncologists and other doctors to learn about long-term effects after cancer
Prof Sophie Fossa
Norwegian Radium Hospital, Oslo, Norway

2:50 p.m.

Why patient recorded quality of life data are more important parameters in trials?
Prof Lesley Fallowfield
Psychosocial Oncology Group, University of Sussex, Brighton, UK

3:10 p.m. The role of palliation and supportive care in effective cancer management
Dr Nigel Sykes St Christopher Hospice, London, UK

3:30 p.m. Palliative care: An Asian perspective
Dr Cynthia Goh
Department of Palliative Medicine, National Cancer Centre Singapore, Singapore

3:50 p.m. The declaration of Venice: A global palliative care research initiative, with a special focus on developing countries
Dr Marilẻne Filbet
Palliative Care Unit, Central Hospital, University of Lyon, Lyon, France

4:10 p.m. TEA BREAK
POSTER DISCUSSION SESSION

Moderator
Prof John Zalcberg
Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia

4:42 p.m. Effect of oral pilocarpine on treatment-related morbidity in patients receiving curative radiotherapy for head and neck cancers
Dr Shikha Goyal
Department of Radiotherapy and Oncology, All India Institute of Medical Sciences, New Delhi, India

4:49 p.m. New Prognostic Score to Predict Distant Metastasis in Nasopharyngeal Carcinoma Following Conformal Radiotherapy
Dr Skye Cheng
Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan

4:56 p.m. 99mTc-Glucarate, a potential radiopharmaceutical for assessment of tumour viability: from bench to bedside
Dr Partha Choudhury
Department of Nuclear Medicine, Rajiv Gandhi Cancer Institute & Research Center, Delhi, India

EMERGING TECHNOLOGIES AND ECONOMIC REALITIES

Moderator
Prof John Zalcberg
Department of Medical Oncology, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

5:10 p.m. Non-FDG-based PET/CT in oncology
Prof Peter Ell
Institute of Nuclear Medicine, University College London Medical School, London, UK

5:30 p.m. The impact of molecular biology in new anticancer drug development
Prof Gilberto Schwartsmann
Hospital de Clinicas de Porto, Alegre Porto Alegre, Brazil

5:50 p.m. Integrating emerging technologies in emerging economies: the radiotherapy scenario
A/Prof Rajiv Sarin
Advanced Centre for Treatment, Research, and Education in Cancer, Tata Memorial Cancer Centre, Mumbai, India

6:10 p.m. Role of computer-assisted surgery in the present and future
Dr. Khurshid Ahad Guru
Roswell Park Cancer Institute, New York, USA

6:30 p.m.
Keynote Lecture 4:
Paying for modern cancer care – can we afford it?

Prof Sir Michael Rawlins
National Institute for Health & Clinical Excellence, London, UK

7:00 p.m. END OF FORUM
Note: Programme subject to change.

Comments (0 posted):

Post your comment comment

Please enter the code you see in the image:

  • email Email to a friend
  • print Print version
  • Plain text Plain text
Tags
No tags for this article
Rate this article
0